|
Biomedical
Were the first to introduce synthetic copolymers to
treat infectious and autoimmune diseases. Developed
Copaxone® - an FDA-approved drug treatment for
multiple sclerosis.
Are developing an innovative therapy with activated
immune cells from a patient's own body, to treat and
possibly repair spinal cord injuries. Regeneration
of the central nervous system has, until now,
been assumed to be unachievable.
Were the first to use cells from the amniotic fluid
surrounding the human fetus, for diagnostic
purposes. Amniocentesis is now commonly used for
prenatal diagnosis of possible genetic defects.
Are developing diagnostic kits and treatments for
juvenile diabetes.
Cancer
Have contributed to understanding the molecular
basis of cancer and to the increasing capabilities in
treating it.
Were the first to accurately describe the multistep
nature of carcinogenesis and metastasis.
Discovered the mechanism of molecular regulation
of blood-cell formation that became the basis for
treatment of certain blood cancers.
Participated in the team that discovered and cloned
the most important tumor suppressor gene - p53,
and are among the leaders in the world in
elucidating how mutations in the p53 gene lead to
the formation of cancerous tumors.
Were pioneers in developing Magnetic Resonance
Imaging (MRI) and Spectroscopy as tools to distinguish between benign and malignant breast tumors.
This non-invasive technique may replace surgical
biopsy for diagnosis of breast tumors, and
may also be used to diagnose other cancerous tumors.
Physics
Made a critical contribution to the development of
the conventional theory of the structure of matter.
This theory describes the nature of the elementary
particles that make up the atom and how they
interact with each other.
Designed the world's most advanced particle
detectors, for use in high-energy collisions at
accelerators at CERN in Switzerland and
Brookhaven on Long Island.
Contributed decisively to understanding the
collective movement of protons and neutrons
observed in certain regions of atomic nuclei. This
breakthrough involved devising innovative
experimental techniques that were later adopted by
other research centers around the world.
Nanotechnology
The age of smart and ultra-miniaturized materials - i.e., materials constructed from the atomic or molecular level - is opening one of the most exciting
developments in scientific research today. Weizmann
scientists are at the forefront of this new discipline.
Developed layers of the world's purest gallium
arsenide semiconductor material, allowing the
production of electronic devices that are faster and
more efficient than silicon ones.
Synthesized both organic and inorganic molecules that
can function as switches. Utilization of a molecular
switch of this sort would be a big step towards
producing ultra-miniature molecular memory units
for computers.
Designed a theoretical model for a biomolecular
computer, which, when developed, could be
inserted inside the human body as a therapeutic
device. This ultra-small computer would react to
the body's physiological conditions and make
necessary corrections in protein biosynthesis to
achieve optimal bodily functioning.
Environment
Devised solar energy technology for use in
disinfection of sewage water that is being tested at
a pilot plant in Israel.
Are developing a commercially feasible solar power
plant, in collaboration with American and Israeli
companies, at the Institute's solar tower - one of
only three such facilities in the world.
Click here to contact us American Committee for the Weizmann Institute of Science
130 East 59th Street, New York, NY 10022 Phone: 212/779-2500 Fax: 212/779-3209 www.weizmann-usa.org
|